ラジオイムノアッセイ市場：タイプ、製品タイプ、用途、エンドユーザー別-2025～2030年の世界予測

ラジオイムノアッセイ市場は、2023年に4億4,894万米ドルと評価され、2024年には4億6,861万米ドルに達すると予測され、CAGR 4.52%で成長し、2030年には6億1,200万米ドルに達すると予測されています。

ラジオイムノアッセイ（RIA）は、放射性標識物質を用いて抗原やホルモンレベルを測定する先進的技術を提供し、臨床と研究の両方の場面で重要な役割を果たしています。RIAの必要性は、その高感度で特異的な診断能力にあり、主に免疫学、腫瘍学、内分泌学、薬理学に応用されています。RIAは、ホルモン機能の解明、慢性疾患の診断、新薬の発見などに重点を置く研究所では不可欠な機能を果たしています。RIAの最終用途は、病院、診断センター、研究機関だけでなく、精密で正確なバイオマーカー検出が重要な製薬会社やバイオテクノロジー会社にも及んでいます。RIAsの市場は、慢性疾患の有病率の上昇、個別化医療に対する需要の高まり、精密診断の進歩などから大きな影響を受けています。しかし、市場は、放射性標識物質に関連する高コスト、厳しい規制ガイドライン、ELISAのような非放射性代替物質への緩やかなシフトといった課題にも直面しています。このような制約があるにもかかわらず、アッセイプロセスの自動化の強化や、RIAの適用範囲を広げる可能性のあるハイブリッドアッセイの開発など、技術革新によって新たな機会が生まれています。企業は、アッセイの小型化や放射性被ばくリスクの低減といった制約を克服するための研究開発に投資することで、こうした機会を活用することができます。さらに、学術機関との共同研究や提携を拡大することで、新規バイオマーカー研究の道を開くことができます。市場の成長を維持するためには、試薬コストを最小限に抑え、RIAプロセスの環境に優しい側面を改善することが極めて重要です。RIA市場は緩やかな成長を示しているが、個別化医療やバイオテクノロジーセグメントにおける技術革新や未開拓アプリケーションの開拓に注力することで、事業の大幅な成長が期待できます。市場は、伝統的手法と新たなデジタル代替技術の間でダイナミックに推移しており、継続的な適応と新規アッセイ技術への戦略的投資が、持続的な成功には不可欠です。

市場力学：急速に進化するラジオイムノアッセイ市場の主要市場洞察を公開

ラジオイムノアッセイ市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 慢性疾患と感染症の蔓延
  • 世界中で増加する画像診断センター
  • 早期診断への急速なシフトと医療支出の急増
• 市場抑制要因
  • 保存期間の短さと放射性物質による危険性の懸念
• 市場機会
  • 生命科学研究活動に対する政府資金の急増
  • 疾病診断のための先端技術の統合
• 市場課題
  • 代替の高度免疫測定法の存在と熟練した専門家の不足

ポーターのファイブフォース：ラジオイムノアッセイ市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ラジオイムノアッセイ市場における外部からの影響の把握

外部マクロ環境要因は、ラジオイムノアッセイ市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：ラジオイムノアッセイ市場における競合情勢の把握

ラジオイムノアッセイ市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：ラジオイムノアッセイ市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ラジオイムノアッセイ市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：ラジオイムノアッセイ市場における成功への道筋を描く

ラジオイムノアッセイ市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患と感染症の蔓延の増加
    • 世界中で画像診断センターが増加
    • 早期診断への急速な移行と医療費の急増
  • 抑制要因
    • 放射性物質の保存期間の短さとそれに伴う危険性の懸念
  • 機会
    • 生命科学研究活動に対する政府資金の急増
    • 疾病診断のための先進技術の統合
  • 課題
    • 代替となる先進的免疫測定法の存在と熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 ラジオイムノアッセイ市場：タイプ別

• イントロダクション
• コーティングチューブRIA
• 二重抗体RIA

第7章 ラジオイムノアッセイ市場：製品タイプ別

• イントロダクション
• アナライザ
• 試薬とキット

第8章 ラジオイムノアッセイ市場：用途別

• イントロダクション
• 臨床診断
• 研究

第9章 ラジオイムノアッセイ市場：エンドユーザー別

• イントロダクション
• 学術研究機関
• 臨床診断ラボ
• 病院
• 製薬とCRO

第10章 南北アメリカのラジオイムノアッセイ市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋のラジオイムノアッセイ市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのラジオイムノアッセイ市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbexa Limited
• Abcam Plc
• ALPCO
• Antigenix America, Inc.
• Berthold Technologies GmbH & Co.KG
• Biosynth Ltd
• BioVendor-Laboratorni medicina a.s.
• Creative Biomart, Inc.
• Danaher Corporation
• Demeditec Diagnostics GmbH
• Diasorine S.P.A.
• DRG International, Inc. by BioCheck Inc.
• Drive DeVilbiss International
• EUROIMMUN Medizinische Labordiagnostika AG
• Hidex Oy.
• IBL International GmbH
• Immuno-Biological Laboratories, Inc.
• Institute of Isotopes Co. Ltd.
• LKB Instruments
• LubioScience GmbH
• Marin Biologic Laboratories, Inc.
• Merck & Co, Inc
• Montreal BIoTech Inc.
• MP Biomedicals, LLC
• NovoLytix GmbH
• Padyab Teb Co.
• PerkinElmer Inc.

LIST OF FIGURES

• FIGURE 1. RADIOIMMUNOASSAYS MARKET RESEARCH PROCESS
• FIGURE 2. RADIOIMMUNOASSAYS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. RADIOIMMUNOASSAYS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. RADIOIMMUNOASSAYS MARKET DYNAMICS
• TABLE 7. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY COATED-TUBE RIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY DOUBLE-ANTIBODY RIA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY REAGENTS & KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY CLINICAL DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL RADIOIMMUNOASSAYS MARKET SIZE, BY PHARMACEUTICALS & CROS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CANADA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES RADIOIMMUNOASSAYS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. CHINA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 61. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 62. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 63. INDIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 73. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 89. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 110. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 122. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 129. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 131. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. ITALY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 134. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 146. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 148. POLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 149. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 150. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 151. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 152. QATAR RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 154. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 158. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 162. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 166. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 170. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 174. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 178. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM RADIOIMMUNOASSAYS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 189. RADIOIMMUNOASSAYS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 190. RADIOIMMUNOASSAYS MARKET, FPNV POSITIONING MATRIX, 2023

The Radioimmunoassays Market was valued at USD 448.94 million in 2023, expected to reach USD 468.61 million in 2024, and is projected to grow at a CAGR of 4.52%, to USD 612.00 million by 2030.

Radioimmunoassays (RIA) offer a sophisticated technique for measuring antigens and hormone levels through the use of radiolabeled substances, playing a crucial role in both clinical and research settings. The necessity of RIAs lies in their highly sensitive and specific diagnostic capability, applicable mostly in immunology, oncology, endocrinology, and pharmacology. RIAs serve an essential function in laboratories focused on understanding hormone functions, diagnosing chronic diseases, and discovering new drugs. The end-use scope of RIAs encompasses hospitals, diagnostic centers, and research institutions, as well as pharmaceutical and biotechnology companies where precise and accurate biomarker detection is critical. The market for RIAs is significantly influenced by the rising prevalence of chronic diseases, growing demand for personalized medicine, and advancements in precision diagnostics. However, the market also faces challenges such as the high cost associated with radio-labeled substances, stringent regulatory guidelines, and the gradual shift toward non-radioactive alternatives like ELISA. Despite these constraints, new opportunities emerge with technological innovations, such as enhanced automation in assay processes and development of hybrid assays that can potentially expand the reach of RIAs. Companies can leverage these opportunities by investing in R&D to overcome limitations, such as assay miniaturization and the reduction of radioactive exposure risks. Additionally, expanding collaborations or partnerships with academic institutions can open pathways for novel biomarker research. It is crucial to minimize reagent costs and improve the eco-friendly aspects of RIA processes to sustain market growth. While the RIA market shows moderate growth, the focus on innovation and exploration of untapped applications in personalized medicine and biotechnology sectors can offer substantial business growth. The market remains dynamically poised between traditional methods and emerging digital alternatives, making continuous adaptation and strategic investments in novel assay technologies imperative for sustained success.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Radioimmunoassays Market

The Radioimmunoassays Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing prevalence of chronic and infectious disease
  • Increasing number of imaging centers across the globe
  • Rapid shift towards early diagnosis and surge in healthcare expenditure
• Market Restraints
  • Short shelf life and associated hazards concern with radioactive materials
• Market Opportunities
  • Surge in government funding for life science research activity
  • Integration of advanced technology for disease diagnostics
• Market Challenges
  • Presence of alternative advanced immunoassays and the dearth of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Radioimmunoassays Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Radioimmunoassays Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Radioimmunoassays Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Radioimmunoassays Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Radioimmunoassays Market

A detailed market share analysis in the Radioimmunoassays Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Radioimmunoassays Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Radioimmunoassays Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Radioimmunoassays Market

A strategic analysis of the Radioimmunoassays Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Radioimmunoassays Market, highlighting leading vendors and their innovative profiles. These include Abbexa Limited, Abcam Plc, ALPCO, Antigenix America, Inc., Berthold Technologies GmbH & Co.KG, Biosynth Ltd, BioVendor - Laboratorni medicina a.s., Creative Biomart, Inc., Danaher Corporation, Demeditec Diagnostics GmbH, Diasorine S.P.A., DRG International, Inc. by BioCheck Inc., Drive DeVilbiss International, EUROIMMUN Medizinische Labordiagnostika AG, Hidex Oy., IBL International GmbH, Immuno-Biological Laboratories, Inc., Institute of Isotopes Co. Ltd., LKB Instruments, LubioScience GmbH, Marin Biologic Laboratories, Inc., Merck & Co, Inc, Montreal Biotech Inc., MP Biomedicals, LLC, NovoLytix GmbH, Padyab Teb Co., and PerkinElmer Inc..

Market Segmentation & Coverage

This research report categorizes the Radioimmunoassays Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Coated-Tube RIA and Double-Antibody RIA.
• Based on Product Type, market is studied across Analyzers and Reagents & Kits.
• Based on Application, market is studied across Clinical Diagnostics and Research.
• Based on End-User, market is studied across Academic & Research Institutes, Clinical Diagnostic Laboratories, Hospitals, and Pharmaceuticals & CROs.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic and infectious disease
    • 5.1.1.2. Increasing number of imaging centers across the globe
    • 5.1.1.3. Rapid shift towards early diagnosis and surge in healthcare expenditure
  • 5.1.2. Restraints
    • 5.1.2.1. Short shelf life and associated hazards concern with radioactive materials
  • 5.1.3. Opportunities
    • 5.1.3.1. Surge in government funding for life science research activity
    • 5.1.3.2. Integration of advanced technology for disease diagnostics
  • 5.1.4. Challenges
    • 5.1.4.1. Presence of alternative advanced immunoassays and the dearth of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Radioimmunoassays Market, by Type

• 6.1. Introduction
• 6.2. Coated-Tube RIA
• 6.3. Double-Antibody RIA

7. Radioimmunoassays Market, by Product Type

• 7.1. Introduction
• 7.2. Analyzers
• 7.3. Reagents & Kits

8. Radioimmunoassays Market, by Application

• 8.1. Introduction
• 8.2. Clinical Diagnostics
• 8.3. Research

9. Radioimmunoassays Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Clinical Diagnostic Laboratories
• 9.4. Hospitals
• 9.5. Pharmaceuticals & CROs

10. Americas Radioimmunoassays Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Radioimmunoassays Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Radioimmunoassays Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbexa Limited
• 2. Abcam Plc
• 3. ALPCO
• 4. Antigenix America, Inc.
• 5. Berthold Technologies GmbH & Co.KG
• 6. Biosynth Ltd
• 7. BioVendor - Laboratorni medicina a.s.
• 8. Creative Biomart, Inc.
• 9. Danaher Corporation
• 10. Demeditec Diagnostics GmbH
• 11. Diasorine S.P.A.
• 12. DRG International, Inc. by BioCheck Inc.
• 13. Drive DeVilbiss International
• 14. EUROIMMUN Medizinische Labordiagnostika AG
• 15. Hidex Oy.
• 16. IBL International GmbH
• 17. Immuno-Biological Laboratories, Inc.
• 18. Institute of Isotopes Co. Ltd.
• 19. LKB Instruments
• 20. LubioScience GmbH
• 21. Marin Biologic Laboratories, Inc.
• 22. Merck & Co, Inc
• 23. Montreal Biotech Inc.
• 24. MP Biomedicals, LLC
• 25. NovoLytix GmbH
• 26. Padyab Teb Co.
• 27. PerkinElmer Inc.